Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 0 | 1,267 | 294,123 | 35,141 | 10,283 |
| Gross Profit | 0 | 1,267 | 294,123 | 35,141 | 10,283 |
| Operating Expenses | 132,572 | 115,062 | 123,640 | 155,956 | 115,627 |
| Operating Income | -132,572 | -113,795 | 170,483 | -120,815 | -105,344 |
| Other Income | 13,129 | 14,442 | 12,900 | 11,034 | 6,660 |
| Pre-tax Income | -119,443 | -99,353 | 183,383 | -109,781 | -98,684 |
| Income Tax | N/A | N/A | N/A | N/A | -6 |
| Net Income Continuous | -119,473 | -99,353 | 183,383 | -109,781 | -98,678 |
| Net Income | $-119,473 | $-99,353 | $183,383 | $-109,781 | $-98,678 |
| EPS Basic Total Ops | -0.88 | -0.72 | 1.34 | -0.80 | -0.75 |
| EPS Basic Continuous Ops | -0.87 | -0.72 | 1.34 | -0.80 | -0.75 |
| EPS Diluted Total Ops | -0.84 | -0.72 | 1.30 | -0.80 | -0.75 |
| EPS Diluted Continuous Ops | -0.83 | -0.72 | 1.30 | -0.80 | -0.75 |
| EBITDA(a) | $-142,638 | $-123,901 | $161,235 | $-118,621 | $-104,320 |